OCERA THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • August 14th, 2013 • Ocera Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 14th, 2013 Company Industry JurisdictionThis Common Stock Purchase Warrant (the “Warrant”) is issued as of October 1, 2012, by Ocera Therapeutics, Inc., a Delaware corporation (the “Company”), to ________________, or its assigns (the “Holder”). This Warrant is one of a series of Warrants being issued in connection with the sale of Convertible Promissory Notes (the “Notes”) being sold pursuant to the terms of that certain Note and Warrant Purchase Agreement dated as of March 30, 2012 among the Company, the Holder and the other Lenders listed on Exhibit I thereto, as amended by that certain Amendment to Note and Warrant Purchase Agreement and Approval of Subsequent Closing, dated as of October 1, 2012 (collectively, the “Purchase Agreement”). Any capitalized terms used, but not defined, herein shall have the meaning therefor set forth in the Notes.
OCERA THERAPEUTICS, INC. COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • August 14th, 2013 • Ocera Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledAugust 14th, 2013 Company Industry JurisdictionThis Common Stock Purchase Warrant (the “Warrant”) is issued as of March 30, 2012, by Ocera Therapeutics, Inc., a Delaware corporation (the Company”), to ________________, or its assigns (the “Holder”). This Warrant is one of a series of Warrants being issued in connection with the sale of Convertible Promissory Notes (the “Notes”) being sold pursuant to the terms of that certain Note and Warrant Purchase Agreement dated as of March 30, 2012 among the Company, the Holder and the other Lenders listed on Exhibit I thereto (the “Purchase Agreement”). Any capitalized terms used, but not defined, herein shall have the meaning therefor set forth in the Notes.